{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Inherited white matter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_clonazepam",
          "name": "Clonazepam"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic acid"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_gabapentin",
          "name": "Gabapentin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_phenytoin",
          "name": "Phenytoin"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_topiramate",
          "name": "Topiramate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_lamotrigine",
          "name": "Lamotrigine"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_lacosamide",
          "name": "Lacosamide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_oxcarbazepine",
          "name": "Oxcarbazepine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_divalproex_sodium",
          "name": "Divalproex sodium"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_baclofen",
          "name": "Baclofen"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_zonisamide",
          "name": "Zonisamide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_target_gaba",
          "type": "Target",
          "label": "GABA_A Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_na",
          "type": "Target",
          "label": "Sodium Channel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_wp1",
          "type": "Pathway",
          "label": "GABAergic Signaling Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_wp2",
          "type": "Pathway",
          "label": "Sodium Channel Inhibition Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_wp3",
          "type": "Phenotype",
          "label": "Inherited White Matter Disorders Symptoms",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Inherited White Matter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_clonazepam",
          "target": "n_target_gaba",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Clonazepam与GABA_A受体的相关性"
        },
        {
          "source": "drug_valproic_acid",
          "target": "n_target_gaba",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Valproic acid显示了对GABA_A受体的作用"
        },
        {
          "source": "drug_gabapentin",
          "target": "n_target_na",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Gabapentin作用于钠通道"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_target_na",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Carbamazepine抑制钠通道活动"
        },
        {
          "source": "drug_phenytoin",
          "target": "n_target_na",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Phenytoin与钠通道的抑制作用"
        },
        {
          "source": "drug_topiramate",
          "target": "n_target_na",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Topiramate抑制Na+通道"
        },
        {
          "source": "n_target_gaba",
          "target": "n_wp1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "重要通路：GABAergic Signaling"
        },
        {
          "source": "n_target_na",
          "target": "n_wp2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "重要通路：钠通道抑制"
        },
        {
          "source": "n_wp1",
          "target": "n_wp3",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "GABA的作用影响遗传白质病症状"
        },
        {
          "source": "n_wp2",
          "target": "n_wp3",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "钠通道的抑制也影响相同症状"
        },
        {
          "source": "drug_clonazepam",
          "target": "H1",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "形成机制连接以支持假设H1"
        },
        {
          "source": "drug_valproic_acid",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "形成机制连接以支持假设H2"
        },
        {
          "source": "drug_gabapentin",
          "target": "H3",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "形成机制连接以支持假设H3"
        },
        {
          "source": "drug_carbamazepine",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "形成机制连接以支持假设H4"
        },
        {
          "source": "drug_phenytoin",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "形成机制连接以支持假设H5"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "药物作用于GABA_A受体与钠通道，对遗传白质病症状有影响",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物能够到达靶器官并对症状产生影响（常识性判断）"
    ],
    "uncertainties": [
      "药物对大脑白质的具体影响尚不明确（需后续研究）"
    ],
    "next_focus_for_pi": [
      "是否需要评估更多药物与遗传白质疾病的关联？"
    ]
  }
}